S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
NASDAQ:ARDS

Aridis Pharmaceuticals Earnings Date, Estimates & History

$6.83
-0.18 (-2.57 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.82
Now: $6.83▼
$7.04
50-Day Range
$6.19
MA: $7.09▼
$7.97
52-Week Range
$3.80
Now: $6.83▼
$10.18
Volume1,247 shs
Average Volume10,787 shs
Market Capitalization$68.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.11

Earnings

Aridis Pharmaceuticals (NASDAQ:ARDS) Earnings Information

Aridis Pharmaceuticals last posted its earnings results on November 19th, 2020. The reported ($0.65) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by $0.10. Aridis Pharmaceuticals has generated ($3.51) earnings per share over the last year. Aridis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 14th, 2021 based off prior year's report dates.

Aridis Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aridis Pharmaceuticals (NASDAQ:ARDS) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.34 EPS
Next Year EPS Consensus Estimate: $-2.43 EPS

Aridis Pharmaceuticals (NASDAQ ARDS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/14/2021
(Estimated)		       
11/19/20209/30/2020($0.55)($0.65)($0.65)N/A
8/11/2020Q2 2020($0.7440)($0.47)($0.47)$0.75 million$1.00 millionN/A
5/12/2020Q1 2020($0.67)($0.73)($0.73)$0.75 millionN/A
4/8/2020Q4($0.8080)($0.63)($0.63)N/A
11/13/2019Q3($0.33)($0.87)($0.87)$1.50 millionN/A
8/12/2019Q2 2019($0.84)($1.03)($1.03)N/A
5/14/2019Q1($0.8670)($0.99)($0.99)$1.02 millionN/A
3/28/2019Q4($1.5530)($0.67)($0.67)$0.30 million$1.39 millionN/A
11/13/2018Q3 2018($1.05)($1.97)($1.27)$0.33 million$1.02 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.